Skip to main content
Caplight Logo









Aspect Analytics

Aspect Analytics

Private
GenkHealthcare & Life Scienceshttps://www.aspect-analytics.com/

Last Round

Series A

Sep 9, 2025

Total Funding Raised

$13.56M

Company Overview

Aspect Analytics is a life sciences and software company that provides a cloud-based software platform for spatial multi-omics data management and analysis.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Healthcare Analytics, Biotechnology, Data Visualization

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

mass spectrometry data analysismass spec softwareomics data analysisspatial biologybiomarker discoverydrug discoverybioinformatics softwaredrug metabolism studiessmall molecule identificationmetabolomics analysisspatial omicslife science softwarecontract research organizationCROsAI drug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Aspect Analytics Comparables

Compare Aspect Analytics with similar companies based on industry and business-model similarity.

Aspect Analytics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Danaher
74%
Thermo Fisher Scientific Inc.
72%
Bruker
72%

Aspect Analytics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 9, 2025
SeedAug 30, 2022
GrantDec 9, 2019

Key People

Founding team and executive leadership

Marc Claesen

Founder Chief Technology Officer

Founding Team

Aspect Analytics Investors

Notable investors and investment history

Aspect Analytics investors
InvestorRounds
Capricorn PartnersSeries A
KU Leuven Research & Development (LRD)Series A
EIT HealthGrant
KU LeuvenSeed, Series A
HERAN PartnersSeries A, Seed
PMVSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 9, 2025

    $12M round closed

  • Nov 13, 2024

    Monthly visitors increased 57% MoM.

Aspect Analytics Filings

Explore SEC and related filing metadata, where available.

Aspect Analytics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Aspect Analytics's valuation, stock price, and market status.

Is Aspect Analytics a public or private company?

Aspect Analytics is a private company.

What is the current stock price of Aspect Analytics?

Aspect Analytics is a private company, so its shares have no public market price. Caplight tracks Aspect Analytics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Aspect Analytics worth (valuation)?

Valuation information for Aspect Analytics is not publicly available.

Can I buy Aspect Analytics stock?

Aspect Analytics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Aspect Analytics's last funding round?

Aspect Analytics's most recent funding round was Series A on September 9, 2025.

Who are the main investors in Aspect Analytics?

Key investors in Aspect Analytics include Capricorn Partners, HERAN Partners, PMV.

Will Aspect Analytics IPO soon?

No public IPO plans have been announced for Aspect Analytics.

How can I track Aspect Analytics secondary market activity?

Caplight tracks bids, offers, and trades in Aspect Analytics's shares on secondary markets.

Firmographic Details

HeadquartersGenk
Employee Range25
Year Founded2018
Last FundingSep 9, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?